Large infusion, also known as large volume injection, is a medical liquid medicine that is mainly used for intravenous infusion. It occupies an important position in the Chinese healthcare market and is an integral part of the healthcare system. In recent years, with the improvement of medical standards and the growth of medical demand, the scale of China's large infusion market has been expanding.
Some relevant laws, regulations and policies in the large infusion industry.
Market size and growth.
The size of China's large infusion market has reached billions of dollars, and the compound annual growth rate continues to maintain a high level. According to the "2024-2030 China Large Infusion Market Analysis and Investment Prospect Research Report" released by Booz Data, from 2015 to 2022, the market size of China's large infusion industry has shown a trend of increasing year by year. From 178 billion yuan in 2015 to 280 billion yuan in 2022, the average annual growth rate will reach about 73%。This growth is mainly due to the huge demand for healthcare in China and the continuous improvement of the healthcare system. It is expected that in the next few years, with the deepening of medical reform and the advent of an aging society, China's large infusion market will continue to maintain strong growth.
Reasons for this growing trend may include:
1. Aging population: With the acceleration of the aging of the Chinese population, the demand for health care is growing, especially the relatively high demand for infusion ** among the elderly population.
2. Medical reform: In recent years, China has strengthened medical reform to improve the quality and accessibility of medical services, so that more patients can access infusion services.
3. Urbanization: With the acceleration of China's urbanization process, the demand for health care among urban residents is also increasing, and infusion** as one of the common medical services has also benefited.
4. Technological progress: With the continuous progress of medical technology, the research and development and application of new infusion products have also provided new impetus for the development of the large infusion industry.
Market structure. China's large infusion market is mainly dominated by several large pharmaceutical companies, such as China Resources.
Three. 9. Kelun Pharmaceutical, CSPC Pharmaceutical Group, etc. These companies have strong R&D capabilities, production capabilities, and sales networks, accounting for the majority of the market. However, with the opening of the market and the intensification of competition, more and more small and medium-sized enterprises have begun to enter this large infusion market, making the market competition more intense.
Market trends. 1. Product innovation: In order to meet the growing medical demand, the pace of innovation in large infusion products is accelerating. On the one hand, enterprises are constantly improving product quality and safety; On the other hand, it is also developing new areas and product types, such as nutritional infusion, sexual infusion, etc.
2. Environmental protection trend: With the improvement of environmental awareness, the environmental protection of large infusion products has also become a new focus of enterprise competition. Some companies have begun to develop and produce biodegradable and environmentally friendly large infusion products.
3. Intelligent production: In the context of the transformation and upgrading of the manufacturing industry, the intelligence of large infusion production has also become an important trend in the development of the industry. By introducing advanced production equipment and management systems, enterprises can improve production efficiency, reduce costs, and enhance market competitiveness.
Market outlook. China's large infusion market has broad prospects. In the next few years, with the deepening of medical reform and the advent of an aging society, the demand for medical care will continue to grow, providing a broad space for the development of the large infusion market. At the same time, with the advancement of technology and the promotion of innovation, the variety of large infusion products will be more abundant and the quality will be better, which provides a strong impetus for the development of the market. However, in the face of fierce market competition and environmental protection pressure, enterprises need to continuously improve their own strength, increase R&D investment, and strengthen brand building in order to be invincible in the market. In this process, Booz Data will continue to pay attention to industry trends and provide accurate and timely market analysis and suggestions for relevant enterprises and investors.
Recommended Reading:
2024-2030 China Large Infusion Market Analysis and Investment Prospect Research Report.The "2024-2030 China Large Infusion Market Analysis and Investment Prospect Research Report" released by Boss Data introduces the relevant overview of the large infusion industry, the operating environment of China's large infusion industry, analyzes the current situation of China's large infusion industry, the competition pattern of China's large infusion industry, and analyzes the business conditions of key enterprises in China's large infusion industry and the development prospects and investment of China's large infusion industry. If you want to have a systematic understanding of the large infusion industry or want to invest in the large infusion industry, this report is an indispensable and important tool for you.
